Clinical Trials for Mesothelioma Patients: Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma Study Criteria

Read about the study criteria for patients with Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Intervention:
Procedures: DNA methylation analysis; bronchoalveolar lavage; bronchoscopy; diagnostic procedure; endoscopic biopsy; gene expression analysis; needle biopsy

Study Type and Design:
Interventional Diagnostic

Official Title:
Prospective Evaluation of Epigenetic Alterations in Patients With Lung and Esophageal Cancers and Malignant Pleural Mesothelioma

Primary Outcome Measures:
Identification of patients who are suitable candidates for clinical research protocols [ Designated as safety issue: No ]
Biopsies [ Designated as safety issue: No ]

Recruitment Information:
Recruitment Status: Recruiting
Enrollment: 375
Study Start Date: November 2005

If you or a loved one has been doagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.